PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft

NCT01042444

Saphenous Vein Graft Disease Myocardial Ischemia Embolism

TERMINATED NA

VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction

NCT02112877

Chronic Venous Disorder Venous Outflow Obstruction Symptomatic Venous Outflow Obstruction of Iliofemoral Vein

COMPLETED NA

Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated Balloon

NCT07019350

Coronary Artery Disease

RECRUITING NA

Seal-V Safety and Performance Study

NCT01625481

C.Surgical Procedure; Vascular (Peripheral)

COMPLETED PHASE1

Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting

NCT01783639

Carotid Artery Diseases Stroke

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

WIRION system is used as protection device in patients undergoing SVG stenting procedure. This retrospective study collects data on the usability of the WIRION during the procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Saphenous vein graft (SVG) stenting

Opening and stenting of blocked SVG with the use of the WIRION embolic protection filter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients underwent percutaneous intervention (PI) of SVG stenting in which the WIRIONTM system was used.
* Patient is greater than or equal to 18 years of age.